Drugs & Therapy Perspectives

, Volume 7, Issue 4, pp 10–10 | Cite as




  1. 1.
    Lees AJ, Parkinson’s Disease Research Group of the United Kingdom. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson’s disease. BMJ 1995 Dec 16; 311: 602–7CrossRefGoogle Scholar
  2. 2.
    Selegiline reduces need for levodopa in Parkinson’s disease. Drug Ther Perspect 1995 Oct 16; 6(8): 5–8Google Scholar
  3. 3.
    The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 1993 Jan 21; 328: 176–83CrossRefGoogle Scholar
  4. 4.
    Olanow CW, Hauser RA, Gauger L, et al. The effect of deprenyl and levodopa on the progression of Parkinson’s disease. Ann Neurol 1995 Nov; 38: 771–7PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1996

Personalised recommendations